Tsaur I - Search Results

1

HDAC inhibition delays cell cycle progression of human bladder cancer cells in vitro.

Vallo S, Xi W, Hudak L, Juengel E, Tsaur I, Wiesner C, Haferkamp A, Blaheta RA. Vallo S, et al. Among authors: tsaur i. Anticancer Drugs. 2011 Nov;22(10):1002-9. doi: 10.1097/CAD.0b013e32834a2c70. Anticancer Drugs. 2011. PMID: 21822119

2

Postoperative voiding dysfunction in older male renal transplant recipients.

Tsaur I, Jones J, Melamed RJ, Blaheta RA, Gossmann J, Bentas W. Tsaur I, et al. Transplant Proc. 2009 Jun;41(5):1615-8. doi: 10.1016/j.transproceed.2009.01.110. Transplant Proc. 2009. PMID: 19545691

3

Association of intravesical tumor location with metastases to the pelvic lymph nodes in transitional cell cancer of the bladder.

Wedel SA, Jones J, Tsaur I, Ackermann H, Beecken WD, Jonas D, Blaheta R. Wedel SA, et al. Among authors: tsaur i. Am J Med Sci. 2010 Apr;339(4):341-4. doi: 10.1097/MAJ.0b013e3181d2c590. Am J Med Sci. 2010. PMID: 20195146

4

[Gross haematuria as the primary symptom of extramedullary IgM plasmacytoma of the bladder].

Tsaur I, Probst M, Chow KU, Renne C, Cerovac I, Pelekanos C, Juengel E, Wedel SA, Bickeböller R, Karalis A. Tsaur I, et al. Urologe A. 2010 Jul;49(7):850-4. doi: 10.1007/s00120-010-2293-9. Urologe A. 2010. PMID: 20383630 German.

5

Development of urological cancers in renal transplant recipients: 30-year experience at the Frankfurt Transplant Center.

Tsaur I, Karalis A, Probst M, Blaheta RA, Scheuermann EH, Gossmann J, Kachel HG, Hauser IA, Jonas D, Obermüller N. Tsaur I, et al. Cancer Sci. 2010 Nov;101(11):2430-5. doi: 10.1111/j.1349-7006.2010.01676.x. Cancer Sci. 2010. PMID: 20707803 Free PMC article.

6

De novo renal cell carcinoma of native and graft kidneys in renal transplant recipients.

Tsaur I, Obermüller N, Jonas D, Blaheta R, Juengel E, Scheuermann EH, Kachel HG, Karalis A, Probst M. Tsaur I, et al. BJU Int. 2011 Jul;108(2):229-34. doi: 10.1111/j.1464-410X.2010.09856.x. Epub 2010 Nov 10. BJU Int. 2011. PMID: 21070582

7

Combined targeting of the VEGFr/EGFr and the mammalian target of rapamycin (mTOR) signaling pathway delays cell cycle progression and alters adhesion behavior of prostate carcinoma cells.

Wedel S, Hudak L, Seibel JM, Juengel E, Tsaur I, Haferkamp A, Blaheta RA. Wedel S, et al. Among authors: tsaur i. Cancer Lett. 2011 Feb 1;301(1):17-28. doi: 10.1016/j.canlet.2010.11.003. Epub 2010 Nov 30. Cancer Lett. 2011. PMID: 21122981

8

Inhibitory effects of the HDAC inhibitor valproic acid on prostate cancer growth are enhanced by simultaneous application of the mTOR inhibitor RAD001.

Wedel S, Hudak L, Seibel JM, Juengel E, Tsaur I, Wiesner C, Haferkamp A, Blaheta RA. Wedel S, et al. Among authors: tsaur i. Life Sci. 2011 Feb 28;88(9-10):418-24. doi: 10.1016/j.lfs.2010.12.017. Epub 2010 Dec 27. Life Sci. 2011. PMID: 21192952

9

Transitional cell carcinoma of the native urinary tract after kidney transplantation: recommendations following a long-term retrospective analysis.

Tsaur I, Karalis A, Blaheta R, Juengel E, Vallo S, Scheuermann EH, Kachel HG, Waaga-Gasser AM, Chandraker A, Obermüller N, Probst M. Tsaur I, et al. Am J Med Sci. 2011 Jun;341(6):478-83. doi: 10.1097/MAJ.0b013e31820a87f7. Am J Med Sci. 2011. PMID: 21412138

10

Impact of combined HDAC and mTOR inhibition on adhesion, migration and invasion of prostate cancer cells.

Wedel S, Hudak L, Seibel JM, Makarević J, Juengel E, Tsaur I, Wiesner C, Haferkamp A, Blaheta RA. Wedel S, et al. Among authors: tsaur i. Clin Exp Metastasis. 2011 Jun;28(5):479-91. doi: 10.1007/s10585-011-9386-8. Epub 2011 Mar 31. Clin Exp Metastasis. 2011. PMID: 21452015

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

209 results

Search Page

Filters